Page last updated: 2024-11-04

tegafur and Hepatitis C, Chronic

tegafur has been researched along with Hepatitis C, Chronic in 2 studies

Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.

Research Excerpts

ExcerptRelevanceReference
"Though chronic hepatitis C was pointed out before, it had been left untreated for about 5 years."1.35[A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN]. ( Ichikawa, M; Iwakawa, K; Matsumoto, T; Miyauchi, S; Seike, H; Tanaka, Y; Tanisaka, Y; Tsubouchi, E, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanisaka, Y1
Seike, H1
Matsumoto, T1
Tanaka, Y1
Tsubouchi, E1
Miyauchi, S1
Iwakawa, K1
Ichikawa, M1
Tamori, A1
Kawajiri, H1
Takashima, T1
Motoyama, H1
Morikawa, H1
Enomoto, M1
Hirakawa, K1
Kawada, N1

Other Studies

2 other studies available for tegafur and Hepatitis C, Chronic

ArticleYear
[A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:10

    Topics: Angiography; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms;

2009
Could trastuzumab suppress hepatitis C virus in a patient with chronic hepatitis and breast cancer?
    The American journal of gastroenterology, 2011, Volume: 106, Issue:10

    Topics: Aged; Androstadienes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combi

2011